All studies involving A/J


Filter by:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
Ackert1 body size and weight Body weight, body length, body mass index. Aging study, 6mo, 12mo, 20mo. inbred   (32) both 26, 52, 87 wks 2008
Ackert1 DXA Body mass, fat mass, lean mass, bone mineral density and content, body area, bone area. Aging study, 6mo, 12mo, 20mo. inbred   (32) both 26, 52, 87 wks 2008
Albers1 lipid profile
with high-fat diet
Cholesterol, HDL, non-HDL, triglycerides, phospholipids. 4h fast, plasma. Baseline vs. high-fat diet (6wks). inbred   (15) both 6-14wks 1999
Albers1 protein activity assessment
with high-fat diet
Phospholipid transfer protein activity. 4h fast. inbred   (15) both 6-14wks 1999
Bachmanov1 body weight Body weight inbred   (13) m 7-8wks 2011
Bachmanov1 bottle choice test Sodium chloride solution taste threshold. Fluid intake. inbred   (13) m 7-8wks 2011
Bachmanov1 intake monitoring Water intake. Daily. inbred   (13) m 7-8wks 2011
Benavides1 genotype assessment Gpr84 allele assessment. PCR, sequencing. inbred w/CC8   (58) both 6wks 2013
Benoist1 immune cell quantification Regulatory T cells (Treg), thymus, spleen. inbred   (33) m 5-6wks 2007
Berndt1 ventilator
with methacholine
Airway resistance. Baseline vs. methacholine-challenged (several doses). inbred   (37) both 9-12wks 2010
Berndt2 plethysmography
with methacholine
Lung, respiratory function. Baseline vs. methacholine-challenged (several doses). inbred   (29) both 9-12wks 2010
Berndt2 ventilator
with methacholine
Lung, respiratory function. Anesthetized forced oscillation. Baseline vs. methacholine-challenged (several doses). inbred   (29) both 9-12wks 2010
Berndt3 metabolite quantification Vitamin D concentration (serum). inbred   (18) m 11wks 2011
Berndt4 histopathology Lung adenoma frequency and severity at 20mo. Tumor incidence, cancer, aging. inbred   (28) both 87wks 2011
Bodnar1 intake monitoring
with sucrose
Food, caloric, water intake. Baseline and with sucrose (several concentrations). 24h test. inbred   (12) m 13-17wks 2006
Bolivar1 open field test Locomotor activity and exploratory behavior. 5 min test in dark. inbred   (10) both 8-14wks 2000
Bolivar2 fear conditioning test Contextual fear, cued fear. inbred   (8) both 9-20wks 2001
Bolivar3 monitoring system Social interaction (study 1 and study 2). inbred   (7) m 8-12wks 2007
Bolivar4 open field test Locomotor activity, exploratory behavior, habituation scores. 15 min test. inbred   (14) m 8-12wks 2009
Boon1 body weight
with influenza A (H5N1) virus
Influenza A (H5N1) virus (several doses) vs. baseline. inbred   (23) f 6-9wks 2011
Boon1 health assessment
with influenza A (H5N1) virus
Survival rate, influenza A (H5N1) virus (several doses). Strain H5N1 susceptibility score. inbred   (23) f 6-9wks 2011
Bopp1 health assessment
with Plasmodium berghei
Susceptibility, Plasmodium berghei (malaria). Parasitemia in blood and distribution in brain, spleen, lungs, liver. inbred   (31) both 8-12wks 2010
Brayton1 study archive Spontaneous diseases. inbred both 2013
Broad2 genotyping SNP profiling, 131,000+ genomic locations, 1-19,X. inbred   (89) 2009
Brown1 body weight Body weight inbred   (14) both 10wks 2004
Brown1 elevated plus maze Locomotor, exploratory, and anxiety-related behavior. inbred   (14) both 10wks 2004
Brown1 elevated zero maze Locomotor, exploratory, and anxiety-related behavior. inbred   (14) both 10wks 2004
Brown1 light-dark box Anxiety, avoidance behavior. inbred   (14) both 10wks 2004
Brown1 open field test Locomotor, exploratory, and anxiety-related behavior. inbred   (14) both 10wks 2004
Brown2 Barnes circular maze Spatial learning and memory. inbred   (14) both 10-18wks 2004
Brown2 Morris water maze Spatial learning and memory. inbred   (14) both 10-18wks 2004
Brown2 olfactory discrimination task Olfactory-related learning and memory. inbred   (14) both 10-18wks 2004
Brown2 rotarod Latency to fall from accelerating rotarod. 7 day trials. inbred   (14) both 10-18wks 2004
Brown2 visual water box Spatial learning and memory. inbred   (14) both 10-18wks 2004
Brugnara1 complete blood count Hematology. inbred   (10) both 8wks 2013
Brugnara1 ion transport assessment Hematology red cell ion content, ion transport. inbred   (10) both 8wks 2013
Bubier3 monitoring system
with morphine
Induced respiratory depression, time to recovery (for mice that survived), survival data (for mice that did not survive). inbred w/CC8   (8) both 2020
CGD-MDA1 genotyping SNP profiling, 470,000+ genomic locations, 1-19,X,Y,MT. inbred   (142) m 2014
CGD-MDA4 genotyping SNP profiling, 470,000+ genomic locations, 1-19,X,Y,MT. AXB, BXA, BXH, CXB, AKXL w/par   (72) m 2014
CGD-MDA5 genotyping SNP profiling, 470,000+ genomic locations, 1-19,X,Y,MT. B6.A, B6.PWD consomic panels   (53) m 2014
CGDpheno1 body size and weight Body weight and length. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno1 complete blood count Hematology. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno1 DXA Body mass, fat mass, lean mass, bone mineral density. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno1 lipid profile Cholesterol, HDL, triglycerides, free fatty acids. 4h fast, plasma. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno1 metabolic panel Clinical blood chemistry (plasma). 4h fast. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno3 body weight Body weight CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 complete blood count Hematology. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 ECG Wave amplitudes and intervals. Conscious. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 lipid profile Cholesterol, HDL, triglycerides. 4h fast, plasma. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 metabolic panel Glucose (plasma). 4h fast. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 tail cuff Heart rate and blood pressure. Conscious mice. CC diallel w/par   (62) both 8-16wks 2012
Chang1 electroretinography Photoreceptor measures: rod Awave, Bwave, cone Bwave. inbred   (17) both 10-13wks 2008
Chang1 organ dimensions Eye diameter. inbred   (17) both 10-13wks 2008
Chen1 immune cell quantification Natural killer T cells in peripheral blood, spleen, thymus. inbred   (38) both 8-10wks 2011
Chesler2 behavior observation Wildness scoring. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 body size and weight Body weight, body length, tail length. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 colony observation Reproduction, fecundity. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 complete blood count Hematology. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 fat pad weights Gonadal fat pad weight. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 light-dark box Anxiety, avoidance behavior. 10 min test. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 metabolic panel Clinical blood chemistry. 16h fast. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 monitoring system Sleep patterns. Dark period, total, peak activity. Baseline and after sleep deprivation. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 nociception assay Hot plate and pressure on tail. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 open field test Locomotor activity, exploratory, anxiety-related behavior. 10 min test. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 organ weights Heart, kidney weights. CC diallel w/par   (62) both 7-15wks 2011
Chesler3 behavior observation Wildness scoring. CC pre w/par   (367) both 7-15wks 2011
Chesler3 body size and weight Body weight, tail length. CC pre w/par   (367) both 7-15wks 2011
Chesler3 bone dimensions Femur. CC pre w/par   (367) both 7-15wks 2011
Chesler3 colony observation Reproduction, fecundity. CC pre w/par   (367) both 7-15wks 2011
Chesler3 complete blood count Hematology. CC pre w/par   (367) both 7-15wks 2011
Chesler3 fat pad weights Gonadal fat pad weights. CC pre w/par   (367) both 7-15wks 2011
Chesler3 light-dark box Anxiety, avoidance behavior. 10 min test. CC pre w/par   (367) both 7-15wks 2011
Chesler3 metabolic panel Clinical blood chemistry. 16h fast. CC pre w/par   (367) both 7-15wks 2011
Chesler3 monitoring system Sleep patterns. Dark period, total, peak activity. Baseline and after sleep deprivation. CC pre w/par   (367) both 7-15wks 2011
Chesler3 nociception assay Hot plate and pressure on tail. CC pre w/par   (367) both 7-15wks 2011
Chesler3 open field test Locomotor activity, exploratory, anxiety-related behavior. 10 min test. CC pre w/par   (367) both 7-15wks 2011
Chesler3 organ dimensions Kidney length and volume. CC pre w/par   (367) both 7-15wks 2011
Chesler3 organ weights Heart, brain, kidney, spleen, gonadal fat pads, testicle weights. CC pre w/par   (367) both 7-15wks 2011
Chesler4 body weight Body weight DO population w/par   (9) both 12-16wks 2013
Chesler4 light-dark box Anxiety, avoidance behavior. 20 min test. DO population w/par   (9) both 12-16wks 2013
Chesler4 nociception assay Hot plate. DO population w/par   (9) both 12-16wks 2013
Chesler4 open field test Locomotor activity, exploratory, anxiety-related behavior. 20 min test. DO population w/par   (9) both 12-16wks 2013
Chesler4 tail suspension test Frequency climbing, time immobile, latency immobile. 5 min test. DO population w/par   (9) both 12-16wks 2013
Chesler4 visual cliff Anxiety, avoidance behavior. 20 min test. DO population w/par   (9) both 12-16wks 2013
Chesler5 study archive Intestinal microbiome study. inbred   (10) both 2012
Collins1 complete blood count Hematology. CC pre w/par   (139) m 10-14wks 2012
Cowell1 health assessment
with Staphylococcus aureus
Survival rate, Staphylococcus aureus. inbred   (13) f 8wks 2012
Cowell1 hormone quantification
with Staphylococcus aureus
Interleukin 6 levels (serum) after infection with Staphylococcus aureus. Kidney and peritoneal fluid. inbred   (13) f 8wks 2012
Cowell1 in vitro assay
with Staphylococcus aureus
Bacterial load after infection with Staphylococcus aureus. Kidney and peritoneal fluid. In vitro assay. inbred   (13) f 8wks 2012
Crabbe1 balance beam
with ethanol
Ethanol i.p. (several doses) vs. control (saline). Missteps count. 3 beam lengths. inbred   (8) both 8wks 2003
Crabbe1 body weight
with ethanol
Body weight inbred   (8) both 8wks 2003
Crabbe1 grid test
with ethanol
Ethanol injection (several doses) vs. control (saline). Grid habituation, missteps rate. inbred   (8) both 8wks 2003
Crabbe3 body weight
with ethanol
Body weight inbred   (22) both 9-17wks 2003
Crabbe3 rotarod
with ethanol
Baseline and ethanol i.p. 3 fixed speeds (several doses) and accelerating. inbred   (22) both 9-17wks 2003
Crabbe4 alcohol quantification
with ethanol
Blood alcohol concentration after ethanol 2 g/kg i.p., several timepoints. inbred   (21) both 9-17wks 2003
Crabbe4 dowel balance test
with ethanol
Latency to fall 0 min and 30 min post-injection, 2 widths. Ethanol 2 g/kg. inbred   (21) both 9-17wks 2003
Crabbe4 grip strength
with ethanol
Baseline vs. 30 min after ethanol 2 g/kg i.p. inbred   (21) both 9-17wks 2003
Crabbe4 vertical wire mesh
with ethanol
Latency to fall 30 min post-injection. Ethanol 2 g/kg i.p. inbred   (21) both 9-17wks 2003
Crabbe5 parallel rod floor test
with ethanol
Parallel rod balance test, baseline vs. ethanol 2 g/kg i.p.. inbred   (8) both 7-14wks 2005
Crowley1 behavior observation
with haloperidol
Observed involuntary repetitive movement. Baseline vs. during and after haloperidol 60d implant (several timepoints). inbred w/CC8   (27) m 9-28wks 2012
Crowley1 body weight
with haloperidol
Baseline vs. after haloperidol 60d implant. inbred w/CC8   (27) m 9-28wks 2012
Crowley1 drug and metabolite quantification
with haloperidol
Haloperidol concentration (plasma). Baseline vs. during and after haloperidol 60d implant (several timepoints). inbred w/CC8   (27) m 9-28wks 2012
Crowley1 inclined screen test
with haloperidol
Baseline vs. during and after haloperidol 60d implant (several timepoints). inbred w/CC8   (27) m 9-28wks 2012
Crowley1 open field test
with haloperidol
Locomotor activity, exploratory behavior, involuntary movement. Baseline vs. haloperidol 60d implant (several timepoints). 60 min test. inbred w/CC8   (27) m 9-28wks 2012
Deschepper1 body weight Body weight inbred   (13) both 10wks 2004
Deschepper1 organ weights Heart, kidney, thymus, adrena weights. inbred   (13) both 10wks 2004
Deschepper1 tail cuff Blood pressure. inbred   (13) both 10wks 2004
Dickson1 operant conditioning chamber Sign tracking and goal tracking paradigm with Pavlovian conditioned approach. inbred   (5) both 12-20wks 2015
Dietrich1 in vitro assay
with Bacillus anthracis lethal toxin
Bacillus anthracis lethal toxin (anthrax) susceptibility. inbred   (50) f 6-8wks* 1998
DiPetrillo1 urinalysis Microalbumin, creatinine, ratio. inbred w/CC7   (34) m 10wks 2012
DiPetrillo2 urinalysis Microalbumin, creatinine, ratio. CC pre w/par   (163) m 10wks 2012
Donahue1 DXA Body mass, fat mass, lean mass, bone mineral density and content, craniofacial dimensions. inbred w/CC7   (30) both 15-16wks 2002
Donahue1 hormone quantification Osteocalcin, insulin-like growth factor 1. inbred w/CC7   (30) both 15-16wks 2002
Donahue1 metabolic panel Thyroxine (serum). inbred w/CC7   (30) both 15-16wks 2002
Donahue16 DXA Body mass, fat mass, bone mineral density. B6.A consomic w/par   (23) both 24-29wks 2012
Donahue18 body weight Pup body weight at day 3. inbred   (15) f 6-8wks 2010
Donahue18 colony observation Reproduction, fecundity. Litter size, percent survival to day 3. inbred   (15) f 6-8wks 2010
Donahue18 monitoring system Gestation duration and weight gain during pregnancy. inbred   (15) f 6-8wks 2010
Donahue19 body weight Pup body weight at day 3. B6.A consomic w/par   (22) f 6-8wks 2010
Donahue19 colony observation Reproduction, fecundity. Litter size, percent survival to day 3. B6.A consomic w/par   (22) f 6-8wks 2010
Donahue19 monitoring system Gestation duration and weight gain during pregnancy. B6.A consomic w/par   (22) f 6-8wks 2010
Donahue3 hole board test Exploratory behavior. 10 min test. B6.A consomic w/par   (22) both 6-7wks 2011
Donahue3 open field test Locomotor activity, anxiety-related behavior, involuntary movement. 10 min test. B6.A consomic w/par   (22) both 6-7wks 2011
Donahue5 immune cell quantification White blood cell and immune cell differentials. B6.A consomic w/par   (22) both 7wks 2011
Donahue7 immunoglobulin quantification Immunoglobulin concentrations (plasma). B6.A consomic w/par   (22) both 9wks 2012
Everett1 body weight Body weight inbred   (14) both 9-12wks 2003
Everett1 bone dimensions Craniofacial bone dimensions. inbred   (14) both 9-12wks 2003
Evsikova1 body weight Body weight inbred   (14) both 25wks 2009
Evsikova1 intake monitoring Food intake, water intake at 6mo. Light phase, dark phase, total. inbred   (14) both 25wks 2009
Evsikova1 monitoring system Locomotor activity. Aging study. 24h test with 12h light and 12h dark phases. inbred   (14) both 25wks 2009
Ferris1 body weight
with influenza A (H1N1) virus
Body weight CC pre w/par   (163) f 8-16wks 2012
Ferris1 health assessment
with influenza A (H1N1) virus
Clinical health assessment score and strain susceptibility index 4 days after infection with influenza A (H1N1) virus. CC pre w/par   (163) f 8-16wks 2012
Ferris1 histopathology
with influenza A (H1N1) virus
Lungs and airway 4 days after infection with influenza A (H1N1) virus. CC pre w/par   (163) f 8-16wks 2012
Ferris1 in vitro assay
with influenza A (H1N1) virus
Viral replication log titer 4 days after infection with influenza A (H1N1) virus. In vitro. CC pre w/par   (163) f 8-16wks 2012
Finn1 bottle choice test
with ethanol
Voluntary consumption of ethanol, and ethanol with saccharin (several doses in water). inbred   (22) both 8-12wks 2007
Flaherty1 elevated zero maze Anxiety-related behaviors. inbred   (8) both 8-9wks 2001
Frankel1 electroconvulsion test
with lamotrigine
Electroconvulsive thresholds. Lamotrigine. 2 test sites. inbred   (16) both 6-11wks 2000
Gershenfeld1 light-dark box
with imipramine
Anxiety-related behavior. Baseline (saline) vs. imipramine i.p. 10 min test. inbred   (12) m 5-10wks 2003
Gershenfeld1 open field test
with imipramine
Locomotor activity, exploratory and anxiety-related behavior. Baseline (saline) vs. imipramine i.p. inbred   (12) m 5-10wks 2003
Gershenfeld1 tail suspension test
with imipramine
Immobility. Baseline (saline) vs. imipramine i.p. 6 min test. inbred   (12) m 5-10wks 2003
GMC01 open field test Locomotor, exploratory, and anxiety-related behavior. 20 min test some at 5 min intervals. inbred w/CC8   (8) both 8-9wks 2020
GMC02 grip strength Several trials. inbred w/CC8   (8) both 8-10wks 2020
GMC03 observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). inbred w/CC8   (8) both 8-10wks 2020
GMC04 rotarod Latency to fall from accelerating rotarod. inbred w/CC7   (7) both 9-10wks 2020
GMC05 acoustic startle test Acoustic startle response, prepulse inhibition. inbred w/CC8   (8) both 9-10wks 2020
GMC06 lipid profile Cholesterol, HDL, non-HDL, triglycerides, fatty acids. 16h fast, plasma. inbred   (5) both 10-11wks 2020
GMC06 metabolic panel Glucose, glycerol. 16h fast. inbred   (5) both 10-11wks 2020
GMC07 nociception assay Hot plate (two trials). inbred w/CC8   (8) both 11-12wks 2020
GMC08 transepidermal water loss test Transepidermal water loss in condenser chamber. inbred w/CC8   (8) both 11-12wks 2020
GMC09 intake monitoring Food, water intake. 21h test. inbred w/CC8   (8) both 12-13wks 2020
GMC09 monitoring system Locomotor activity and energy metabolism. 21h test. inbred w/CC8   (8) both 12-13wks 2020
GMC10 NMR Body mass, fat and lean tissue mass. inbred w/CC8   (8) both 12-13, 18-19wks 2020
GMC11 glucose tolerance 0 to 120 min after 20% glucose i.p., 16h fast. inbred w/CC8   (6) both 13-14wks 2020
GMC12 echocardiography Cardiovascular function and morphology. inbred w/CC8   (8) both 14-15wks 2020
GMC13 ECG Heart rate and wave intervals. Conscious. inbred   (6) both 14-15wks 2020
GMC14 computed tomography Retinal thickness and fundus vessels. inbred w/CC8   (8) both 14-17wks 2020
GMC14 organ dimensions Axial length of eye. inbred w/CC8   (8) both 14-17wks 2020
GMC14 Scheimpflug imaging Eye lens density. inbred w/CC8   (8) both 14-17wks 2020
GMC14 virtual optomotor Threshold of spatial frequency. inbred w/CC8   (8) both 14-17wks 2020
GMC15 complete blood count Hematology. inbred w/CC8   (8) both 20-21wks 2020
GMC16 lipid profile Cholesterol, triglycerides. No fast, plasma. inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC16 metabolic panel Clinical blood chemistry (plasma). No fast. inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC17 ABR test Auditory brainstem response. inbred w/CC7   (7) both 17-18wks 2020
GMC18 body size and weight Body weight and length. inbred w/CC8   (8) both 17-18wks 2020
GMC18 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. inbred w/CC8   (8) both 17-18wks 2020
GMC18 X-ray Lumbar vertebrae count. inbred w/CC8   (8) both 17-18wks 2020
GMC19 ventilator Lung, respiratory function. inbred w/CC8   (8) f 21-22wks 2020
GMC20 autoantibody quantification Anti-DNA autoantibodies, rheumatoid factor. inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC20 immunoglobulin quantification Immunoglobulins (plasma). inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC21 bone dimensions Tibia bone length. inbred w/CC8   (8) both 20-21wks 2020
GMC21 organ weights Heart, liver, spleen weights. inbred w/CC8   (8) both 20-21wks 2020
GMC22 body weight Body weight and growth curve from 8wks to 21wks. inbred w/CC8   (8) both 8-21wks 2020
Golani1 open field test Locomotor activity, exploratory and anxiety-related behavior. inbred   (8) m 10wks 2003
Gould1 drug and metabolite quantification
with lithium
Lithium concentration in brain tissue and blood serum after lithium (several doses). inbred   (11) m 7-8wks 2011
Gould1 forced swim test
with lithium
Lithium (several doses) vs. control. 6 min test. inbred   (11) m 7-8wks 2011
Gould2 behavior observation
with nicotine
Observed measures of anxiety. Nicotine (high dose) vs. control. 20 min period. inbred   (8) m 8-12wks 2011
Gould2 drug and metabolite quantification
with nicotine
Amount of nicotine and cotinine in blood plasma after nicotine doses. High and lower doses. inbred   (8) m 8-12wks 2011
Gould2 elevated plus maze
with nicotine
Measures of anxiety. Nicotine (high dose) vs. control. 5 min test. inbred   (8) m 8-12wks 2011
Gould2 fear conditioning test
with nicotine
Contextual fear, cued fear. Nicotine (high and several lower doses) vs. control. inbred   (8) m 8-12wks 2011
Gould3 behavior observation
with nicotine
Observed measures of anxiety during nicotine withdrawal. Nicotine (several high doses) vs. control. inbred   (8) m 8-12wks 2011
Gould3 elevated plus maze
with nicotine
Measures of anxiety during nicotine withdrawal. Nicotine (several high doses) vs. control. inbred   (8) m 8-12wks 2011
Gould3 fear conditioning test
with nicotine
Contextual fear, cued fear during nicotine withdrawal. Nicotine (high and several lower doses) vs. control. inbred   (8) m 8-12wks 2011
Gould4 conditioned place preference test
with nicotine
Nicotine preference and learning effect. Nicotine-treated vs. control. 2 trials (day 5, day 10). inbred   (8) m 8-10wks 2014
Graubert1 complete blood count
with ENU
Hematology. inbred   (20) both 9wks; 12-64wks 2006
Graubert1 histopathology
with ENU
Tumor growth frequency rates. ENU mutagen 100 mg/kg vs. control. inbred   (20) both 9wks; 12-64wks 2006
Gros1 genotype assessment
with Candida albicans
C5 allele sufficiency or deficiency. inbred   (36) f 8-12wks 2011
Gros1 in vitro assay
with Candida albicans
Susceptibility to infection with Candida albicans. inbred   (36) f 8-12wks 2011
Gros2 health assessment
with Plasmodium chabaudi
Survival score and susceptibility, Plasmodium chabaudi. inbred   (25) both 8-10wks 2012
Gros2 microscopy
with Plasmodium chabaudi
Percent of Plasmodium chabaudi-infected erythrocytes in blood. inbred   (25) both 8-10wks 2012
Hadsell1 body weight Daily body weight gain of cross-fostered pups. inbred   (31) f 14-18wks 2012
Hadsell1 colony observation Maternal nurturing study. inbred   (31) f 14-18wks 2012
Hadsell2 mineral quantification concentrations of various minerals in milk inbred   (31) f 14-20wks 2018
Hampton1 ECG Heart rate and wave intervals. Conscious. inbred   (17) both 9-12wks 2001
Handel1 body weight Body weight inbred   (14) m 8-10wks 2010
Handel1 organ weights Male reproductive organ weights. Seminal vesicles, testicles. inbred   (14) m 8-10wks 2010
Handel1 sperm count Sperm count. Hemocytometer. inbred   (14) m 8-10wks 2010
Harrill1 body weight
with isoniazid
Body weight. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill1 histopathology
with isoniazid
Liver pathology scores. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill1 lipid profile
with isoniazid
Cholesterol, triglycerides. Hepatic lipids. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill1 metabolic panel
with isoniazid
Alanine transaminase. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill1 organ weights
with isoniazid
Body, liver, kidney weights. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill2 biomarker quantification
with DB289
Kidney injury molecule 1 (KIM-1). DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 body weight
with DB289
DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 drug and metabolite quantification
with DB289
Kidney metabolite (DB75) concentration. DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 metabolic panel
with DB289
Blood urea nitrogen, alanine transaminase, creatinine. DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 organ weights
with DB289
Kidney and liver weights. DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 urinalysis
with DB289
Urine volume, creatinine. DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Haston1 bronchoalveolar lavage assessment
with radiation
Bronchoalveolar cell differential after exposure to radiation (18 Gy). inbred   (26) both 15-36wks 2012
Haston1 health assessment
with radiation
Survival rate and health assessment after exposure to radiation. Number of days without respiratory distress (max 26 wks). inbred   (26) both 15-36wks 2012
Haston1 histopathology
with radiation
Post exposure to radiation. inbred   (26) both 15-36wks 2012
Hawes1 ophthalmoscopy Retinal fundoscopic examination. inbred w/CC7   (41) both 6-7wks 2008
Hawes1 slit lamp Eye morphology. Frequency rates of disorders. inbred w/CC7   (41) both 6-7wks 2008
Hillebrands1 histopathology Kidney pathology at 20mo. inbred   (23) both 87wks 2014
HMDPpheno1 DXA Bone mineral density (whole body, femur, spine). HMDP   (96) m 16wks 2011
HMDPpheno10 metabolite quantification Liver metabolic profiling. Molecular measures of nucleotides, peptides. 16h fast. HMDP   (106) m 16wks 2014
HMDPpheno2 lipid profile Cholesterol, HDL, non-HDL, triglycerides, free fatty acids. 16h fast, plasma. HMDP   (99) m 16wks 2010
HMDPpheno2 NMR Percent fat. HMDP   (99) m 16wks 2010
HMDPpheno3 tail cuff Heart rate and blood pressure. Conscious mice. HMDP   (58) m 9-10wks 2012
HMDPpheno4 fear conditioning test Contextual fear, cued fear. HMDP   (94) m 10wks 2011
HMDPpheno5 complete blood count Hematology. HMDP   (83) m 16wks 2013
HMDPpheno6 metabolite quantification Liver metabolic profiling. Molecular measures of amino acids. 16h fast. HMDP   (106) m 16wks 2014
HMDPpheno7 metabolite quantification Liver metabolic profiling. Molecular measures of carbs, cofactors, vitamins, energy, xenobiotics. 16h fast. HMDP   (106) m 16wks 2014
HMDPpheno8 metabolite quantification Liver metabolic profiling. Molecular measures of lipids (non-lysolipids). 16h fast. HMDP   (106) m 16wks 2014
HMDPpheno9 metabolite quantification Liver metabolic profiling. Molecular measures of lipids (lysolipids). 16h fast. HMDP   (106) m 16wks 2014
Iraqi1 computed tomography
with P.gingivalis and F.nucleatum
Susceptibility to periodontitis. Mice infected with P. gingivalis and F. nucleatum vs. control. CC pre   (23) both 8wks 2013
Jax1 body weight Body weight and growth curve from age 3wks to 10 wks, weighed weekly. inbred   (24) both 8wks 2000
Jax2 MHC haplotype tissue typing Major histocompatibility complex (MHC) H2 haplotype. inbred   (56) both 2000
Jax3 colony observation Reproductive performance. inbred   (33) f various 1991
Jax4 colony observation Appearance, coat color inbred   (61) both 2006
Jax5 colony observation Reproductive performance. inbred   (35) f various 2009
Jax6 study archive Exome genotype data. Fastq files. inbred   (6) m 2013
Jaxpheno5 body weight Body weight and growth curve from age 3wks to 16wks, weighed weekly. inbred   (10) both 3-16wks 2014
Jaxpheno7 grip strength Peak tension. inbred   (6) m 10wks 2010
Jaxpheno7 observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). inbred   (6) m 10wks 2010
Jaxpheno7 rotarod Latency to fall from accelerating rotarod. inbred   (6) m 10wks 2010
Jaxpheno8 ABR test Auditory brainstem response. inbred   (7) m 10-13wks 2010
Jaxpheno8 echocardiography Cardiovascular function and morphology. inbred   (7) m 10-13wks 2010
Jaxwest1 body weight Body weight inbred   (7) both 8-14wks 2003
Jaxwest1 DXA Body mass, fat mass, lean mass, bone mineral density and content (whole body, femur, spine). inbred   (7) both 8-14wks 2003
Jaxwest1 ECG Heart rate and wave intervals. Conscious. inbred   (7) both 8-14wks 2003
Jaxwest1 grip strength Peak tension. inbred   (7) both 8-14wks 2003
Jaxwest1 nociception assay Hot plate. inbred   (7) both 8-14wks 2003
Jaxwest1 tail cuff Heart rate and blood pressure. Conscious mice. inbred   (7) both 8-14wks 2003
Johnson1 ABR test Auditory brainstem response. inbred   (51) both 3-12wks and 15-72wks 2000
Johnson3 ABR test Auditory brainstem response. B6.A consomic w/par   (24) both 23-30wks 2012
Justice2 complete blood count Hematology. inbred   (16) both 12-16wks 2002
Kas1 balance beam Latency to reach target. inbred   (6) m 20-34wks 2009
Kas1 grid test Inverted grid performance. inbred   (6) m 20-34wks 2009
Kas1 home cage monitoring Locomotor activity. inbred   (6) m 20-34wks 2009
Kas1 microscopy Ventral root axon morphology. Nervous system microscopy. inbred   (6) m 20-34wks 2009
Klaassen1 histopathology
with cadmium
Cadmium-induced toxicity to liver, testis, trigeminal ganglia. inbred   (8) m 8wks 2001
Kliethermes1 hole board test Head dipping and other activity measures, hole board with and without objects in two of the holes. 10 min test. inbred   (14) both 8wks 2006
Kliethermes1 monitoring system Activity in a novel environment. Distance traveled, number of rears. 30 min test. inbred   (14) both 8wks 2006
Kliethermes1 two chamber assay Novel environment preference. Activity in familiar and novel compartments. 20 min test. inbred   (14) both 8wks 2006
Kliethermes1 Y-maze Spontaneous alternation. inbred   (14) both 8wks 2006
Korstanje1 urinalysis Microalbumin, creatinine, ratio. Aging study, 6mo, 12mo, and 20mo. inbred   (30) both 52, 78, 104 wks 2008
Korstanje2 histopathology Kidney pathology. Aging study, 6mo, 12mo, 20mo. inbred   (29) m 52, 78, 104 wks 2013
Kumar2 open field test Distance traveled, after first 10 min and after 55 min. other   (58) both 7-26wks 2019
Kumar3 body weight Body weight inbred w/CC8   (62) both 8-14wks 2021
Kumar3 open field test Locomotor activity and grooming behavior. inbred w/CC8   (62) both 8-14wks 2021
Lake1 complete blood count Hematology. B6.A consomic w/par   (23) both 7-11wks 2005
Lake1 ECG Heart rate and wave intervals. Conscious. B6.A consomic w/par   (23) both 7-11wks 2005
Lake1 lipid profile Cholesterol, HDL, triglycerides, fatty acids. 4h fast, plasma. B6.A consomic w/par   (23) both 7-11wks 2005
Lake1 metabolic panel Glucose, bilirubin, aspartate transaminase (plasma). 4h fast. B6.A consomic w/par   (23) both 7-11wks 2005
Lake1 tail cuff Heart rate and blood pressure. Conscious mice. B6.A consomic w/par   (23) both 7-11wks 2005
Lake2 observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). B6.A consomic w/par   (23) both 8wks 2005
Lake3 grip strength 3 trials. B6.A consomic w/par   (23) both 8-9wks 2005
Lake3 hole board test Exploratory, locomotor, and anxiety-related behavior. B6.A consomic w/par   (23) both 8-9wks 2005
Lake3 rotarod Latency to fall from fixed and accelerating rotorods, multiple trials. B6.A consomic w/par   (23) both 8-9wks 2005
Lesage1 immune cell quantification Immunological cell variation. CC w/par   (76) both 5-8wks 2018
Lightfoot1 body weight Body weight inbred   (41) both 8-9wks 2010
Lightfoot1 running wheel monitoring Distance, duration, speed. inbred   (41) both 8-9wks 2010
Lionikas1 body weight
with exercise
Exercise (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 bone dimensions
with exercise
Femur length. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 microscopy
with exercise
Muscle fibers. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 muscle weights
with exercise
Various muscles. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 organ weights
with exercise
Heart weight. Cardiac ventricle weight. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 protein activity assessment
with exercise
Muscle enzyme levels. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 swim endurance test
with exercise
Exercise vs. control, weekly for 5wks. inbred   (6) m 11-14wks 2012
Loos1 home cage monitoring Locomotor activity, avoidance, sheltering, habituation, preference index, aversion index, over several days. inbred   (8) m 8-19wks 2012
Loos2 home cage monitoring Locomotor activity, sheltering, habituation. 3 day home-cage assessment. inbred w/CC7   (11) m 8-12wks 2016
Marchuk1 histopathology Cerebral infarct volume, stroke susceptibility. Surgical occlusion of distal medial cerebral artery (MCA) to induce ischemia. inbred   (16) both 11-13wks 2009
Massett1 body weight Body weight inbred   (34) both 8wks 2012
Massett1 treadmill endurance test Duration, distance, work. inbred   (34) both 8wks 2012
Mathes1 body weight
with exercise
Baseline vs. after exercise (access to running wheel). CC pre w/par   (184) m 10-12wks 2011
Mathes1 intake monitoring
with exercise
Caloric intake. Baseline vs. after exercise (access to running wheel). Metabolism, food intake. CC pre w/par   (184) m 10-12wks 2011
Mathes1 monitoring system
with exercise
Respiratory exchange ratio. Baseline (before access to running wheel). CC pre w/par   (184) m 10-12wks 2011
Mathes1 MRI
with exercise
Body composition (percent fat). Baseline vs. after exercise (access to running wheel). CC pre w/par   (184) m 10-12wks 2011
Mathes1 running wheel monitoring
with exercise
Distance, speed at days 1, 6, and 12. CC pre w/par   (184) m 10-12wks 2011
Maurer1 body weight
with atenolol, isoproterenol
Isoproterenol or atenolol vs. control. inbred   (23) m 10-12wks 2009
Maurer1 ECG
with atenolol, isoproterenol
Heart rate and wave amplitudes and intervals. Unconscious. Isoproterenol or atenolol vs. control. inbred   (23) m 10-12wks 2009
Maurer1 organ weights
with atenolol, isoproterenol
Heart, atria, ventricle weights. Isoproterenol or atenolol vs. control. inbred   (23) m 10-12wks 2009
Maurer1 tail cuff
with atenolol, isoproterenol
Heart rate and blood pressure. Conscious mice. Isoproterenol or atenolol vs. control. inbred   (23) m 10-12wks 2009
Metten1 behavior observation
with ethanol
Observed gait, hindlimb splay 10 min and 30 min after ethanol i.p. (several doses). inbred   (9) both 8-11wks 2004
Metten1 open field test
with ethanol
Locomotor activity. Ethanol i.p. (several doses) vs. control (saline i.p.). 45s test. inbred   (9) both 8-11wks 2004
Mills1 apoptosis assessment Aging study, 6mo, 12mo, 20mo. inbred   (30) both 26, 52, 87 wks 2008
Mills1 chromosome instability assessment Chromosome instability. Aging study, 6mo, 12mo, 20mo. inbred   (30) both 26, 52, 87 wks 2008
Mogil1 nociception assay Battery of tests for mechanical, chemical, thermal nociception. inbred   (12) m 6-18wks 2002
Mogil2 monitoring system Locomotor activity. Light and dark phases. inbred   (12) m 6-10wks 2000
Mogil3 nociception assay von Frey nociception test, baseline and after spared nerve injury (SNI) surgery as a hypersensitizer. inbred   (18) both 7-12wks 2012
Morgan1 body weight
with high-fat diet and olanzapine
Body weight and growth curve from age 8wks to 18wks weighed every 2wks. Olanzapine vs. control (both groups high-fat diet). inbred w/CC8   (9) f 8-18wks 2014
Moy1 three chamber assay Sociability and preference for social novelty. Autism-relevant behaviors. inbred   (17) m 6-7wks 2008
Nadeau1 body weight
with high-fat diet
Baseline vs. high-fat diet for 12wks. B6.A consomic w/par   (24) m 5, 17 wks 2008
Nadeau2 body size and weight
with high-fat high-sucrose diet
Body weight, size, and body mass index after 16wks on high-fat high-sucrose diet. B6.A consomic w/par   (24) m 5, 21 wks 2015
Nadeau2 lipid profile
with high-fat high-sucrose diet
Cholesterol, triglycerides. 16h fast, plasma. Hepatic triglycerides. B6.A consomic w/par   (24) m 5, 21 wks 2015
Nadeau2 metabolic panel
with high-fat high-sucrose diet
Glucose, insulin, insulin resistance after 16wks of high-fat high-sucrose diet. 16h fast. B6.A consomic w/par   (24) m 5, 21 wks 2015
Nadeau2 organ weights
with high-fat high-sucrose diet
Liver weight after 16wks of high-fat high-sucrose diet. 16h fast. B6.A consomic w/par   (24) m 5, 21 wks 2015
Naggert1 body weight
with high-fat diet
High-fat diet for 8wks. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 DXA
with high-fat diet
Body mass, fat mass, lean mass, bone mineral density and content after 8wks on high-fat diet. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 hormone quantification
with high-fat diet
Insulin and leptin after 18wks on high-fat diet. Multiple readings per animal were averaged. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 metabolic panel
with high-fat diet
Glucose (plasma). Baseline vs. high-fat diet (17wks). 4h fast. inbred w/CC7   (43) both 5, 21 wks 2003
Odet1 body weight Body weight inbred   (8) m 10-66wks 2015
Odet1 histopathology Male reproductive histopathology. Percent normal vs. abnormal sperm, seminiferous tubules. inbred   (8) m 10-66wks 2015
Odet1 metabolic panel Male reproductive sperm lactate production. inbred   (8) m 10-66wks 2015
Odet1 organ weights Male reproductive organ weights. Testes, seminal vesicles, epididymis, vas deferens. inbred   (8) m 10-66wks 2015
Odet1 sperm count Sperm count. Hemocytometer. inbred   (8) m 10-66wks 2015
Odet2 microscopy Male reproductive sperm motility. inbred w/CC8   (8) m 10-66wks 2015
Paigen1 body weight
with high-fat diet
Baseline vs. high-fat diet for 8wks. inbred   (44) both 15-19wks 2000
Paigen1 histopathology
with high-fat diet
Gallstone, gallbladder, and atherosclerosis lesion histopathology after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 lipid profile
with high-fat diet
Cholesterol, HDL, non-HDL. 4h fast, plasma. Hepatic lipids. 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 metabolic panel
with high-fat diet
Alanine transaminase, bile salts (plasma) after 8wks on high-fat diet. 4h fast. inbred   (44) both 15-19wks 2000
Paigen1 organ dimensions
with high-fat diet
Gallbladder volume after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 organ weights
with high-fat diet
Liver weight after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen2 histopathology
with high-fat diet
Aortic lesion size histopathology. Baseline vs. high-fat diet (17wks). inbred w/CC7   (43) both 7-9wks, 24-27wks 2002
Paigen2 lipid profile
with high-fat diet
Cholesterol, HDL, non-HDL, triglycerides. Baseline vs. high-fat diet (17wks). 4h fast, plasma. inbred w/CC7   (43) both 7-9wks, 24-27wks 2002
Paigen4 lipid profile Cholesterol, HDL, non-HDL, triglycerides. 4h fast, plasma. inbred w/CC7   (43) both 10wks 2002
Palmer1 fear conditioning test Innate anxiety-like behavior and contextual fear conditioning. B6.A consomic w/par   (19) both 10wks 2007
Palmer2 open field test
with methamphetamine
Locomotor activity and habituation. Baseline (saline) vs. methamphetamine 2 mg/kg i.p. 30 min test. B6.A consomic w/par   (21) both 10wks 2008
Perlegen2 genotyping SNP profiling, 8,100,000+ genomic locations, 1-19,X,Y,MT. inbred   (16) m 2005
Peters1 coagulation test Fibrinogen. inbred w/CC7   (43) both 10wks 2001
Peters1 complete blood count Hematology. inbred w/CC7   (43) both 10wks 2001
Peters4 complete blood count Hematology. Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (30) both 26, 52, 78, 104 wks 2007
Petkova1 complete blood count Hematology. Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (32) both 26, 52, 78, 104 wks 2007
Petkova1 immune cell quantification Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (32) both 26, 52, 78, 104 wks 2007
Pletcher1 body weight Body weight inbred   (32) m 7-9wks 2007
Pletcher1 hormone quantification Corticosterone (serum). inbred   (32) m 7-9wks 2007
Pletcher1 open field test Locomotor and anxiety-related behavior. 10 min test. inbred   (32) m 7-9wks 2007
Pletcher1 tail suspension test Immobility percentage. inbred   (32) m 7-9wks 2007
Poon1 histopathology Cell proliferation in the rostral migratory stream. BrdU+ cells. inbred   (9) both 13-78wks 2013
Powell1 in vitro assay
with Neisseria musculi
Bacterial load after inoculation with Neisseria musculi. Oral cavity. inbred w/CC8   (8) both 8-16wks 2018
Reed1 body size and weight Body weight, body length, body mass index. inbred   (28) m 8, 12 wks 2009
Reed1 fat pad weights Epididymal, retroperitoneal. inbred   (28) m 8, 12 wks 2009
Reed1 organ weights Heart, kidney weights. inbred   (28) m 8, 12 wks 2009
Richfield1 neurotransmitter quantification Neurotransmitters. Molecular measures. inbred   (15) m 7-9wks 2003
Richfield1 open field test Locomotor activity. 3 day trials. 45 min sessions. inbred   (15) m 7-9wks 2003
Rusyn2 drug and metabolite quantification
with trichloroethylene
Trichloroethylene metabolites in serum, 2h, 4h, 24h after trichoroethylene exposure. inbred   (17) m 7wks 2010
Rusyn2 metabolic panel
with trichloroethylene
Blood urea nitrogen, alanine transaminase, aspartate transaminase (serum). Baseline and trichloroethylene-exposed (several timepoints). No fast. inbred   (17) m 7wks 2010
Rusyn6 drug and metabolite quantification
with trichloroethylene
Trichloroethylene metabolite in blood, liver, kidney after trichloroethylene exposure. inbred   (7) m 6-7wks 2014
Rusyn6 histopathology
with trichloroethylene
Kidney histopathology evaluation after trichloroethylene exposure, relative to controls. inbred   (7) m 6-7wks 2014
Rusyn6 metabolic panel
with trichloroethylene
Blood urea nitrogen (serum). Trichloroethylene-exposed vs. control. inbred   (7) m 6-7wks 2014
Rusyn6 organ weights
with trichloroethylene
Liver, kidney weights. Trichloroethylene-exposed vs. control. inbred   (7) m 6-7wks 2014
Rusyn6 RNA expression profiling
with trichloroethylene
Trichloroethylene effect on mRNA gene expression in liver and kidney, relative to controls. inbred   (7) m 6-7wks 2014
Sanger4 genotyping SNP profiling, 80,000,000+ genomic locations. SNPs and indels. 1-19,X. inbred   (37) both 2017
Schalkwyk1 elevated plus maze Anxiety-related and exploratory behavior. 5 min test. inbred   (8) m 9-11wks 2010
Schalkwyk1 light-dark box Anxiety-related behavior. inbred   (8) m 9-11wks 2010
Schalkwyk1 Morris water maze Spatial learning and memory. Multiple trials. inbred   (8) m 9-11wks 2010
Schalkwyk1 open field test Locomotor activity and exploratory behavior. 5 min test. inbred   (8) m 9-11wks 2010
Schalkwyk1 puzzle box Learning and memory. inbred   (8) m 9-11wks 2010
Schalkwyk1 tail suspension test Duration of immobility. Two trials. inbred   (8) m 9-11wks 2010
Schauwecker1 health assessment
with pilocarpine
Study of pilocarpine effect on epilepticus seizures. inbred   (11) m 8-10wks 2012
Schughart3 body weight
with influenza A (H3N2) virus
Influenza A (H3N2) virus (several doses) vs. baseline. Several timepoints. inbred w/CC8   (8) both 7-13wks 2013
Schughart3 health assessment
with influenza A (H3N2) virus
Survival rate, susceptibility, influenza A (H3N2) virus (several doses). inbred w/CC8   (8) both 7-13wks 2013
Schughart4 body weight
with influenza A (H3N2) virus
Influenza A (H3N2) virus vs. controls. Several timepoints. inbred w/CC8   (8) f 8-12wks 2016
Schughart4 complete blood count
with influenza A (H3N2) virus
White blood cell count and differentials. Influenza A (H3N2) virus vs. controls. inbred w/CC8   (8) f 8-12wks 2016
Schughart4 in vitro assay
with influenza A (H3N2) virus
Viral load in lungs after infection with influenza A (H3N2) virus. inbred w/CC8   (8) f 8-12wks 2016
Schughart5 body weight
with influenza A (H3N2) virus
Influenza A (H3N2) virus vs. controls. Several timepoints. inbred w/CC8   (8) f 8-12wks 2016
Schughart5 organ weights
with influenza A (H3N2) virus
Lung weight. Animals infected with influenza A (H3N2) virus vs. controls. inbred w/CC8   (8) f 8-12wks 2016
Schulz1 body weight Body weight inbred   (7) both 9-18wks 2000
Schulz1 ventilator Lung, respiratory function. inbred   (7) both 9-18wks 2000
Schwartz2 bronchoalveolar lavage assessment
with ovalbumin
Lung inflammatory changes. Ovalbumin vs. control. inbred   (8) m 6-8wks 2001
Schwartz4 study archive Lung, respiratory response to ozone. Methacholine-sensitized. inbred   (8) both 2004
Schwartz5 study archive Lung, respiratory response to Streptococcus zooepidemicus. inbred   (8) both 2007
Seburn1 body weight Body weight inbred   (16) both 7-9wks 2001
Seburn1 intake monitoring Food, caloric, and water intake. Daily. inbred   (16) both 7-9wks 2001
Seburn1 monitoring system Locomotor activity and energy metabolism. 24h test. inbred   (16) both 7-9wks 2001
Seburn2 gait analysis Aging study, 6mo, 18mo. inbred   (32) both 26, 52, 78, 104 wks 2008
Seburn2 grip strength Peak tension. 3 trials. Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (32) both 26, 52, 78, 104 wks 2008
Shockley1 body weight
with high-fat diet
High-fat diet for 4wks vs. control. inbred   (10) both 10-13wks 2008
Shockley1 lipid profile
with high-fat diet
Cholesterol, HDL, triglycerides, fatty acids. High-fat diet (4wks) vs. control. 5h fast, serum. inbred   (10) both 10-13wks 2008
Shockley1 metabolic panel
with high-fat diet
Clinical blood chemistry measures (serum). High-fat diet (4wks) vs. control. inbred   (10) both 10-13wks 2008
Shorter3 colony observation Litter size assessment. CC diallel w/par   (62) f 3wks 2018
Spijker2 choice serial reaction time task Choice serial reaction time task. Impulsivity, attention, cognitive flexibility behavior. 25 min test. inbred   (12) m 6wks 2009
Spijker2 elevated plus maze Exploratory and anxiety-related behaviors. 5 min test. inbred   (12) m 6wks 2009
Spijker2 home cage monitoring Exploratory behavior. 4 min and 10 min tests. inbred   (12) m 6wks 2009
Spijker2 light-dark box Anxiety, avoidance behavior. 5 min test. inbred   (12) m 6wks 2009
Spijker2 open field test Locomotor activity and exploratory behavior. 10 min test. inbred   (12) m 6wks 2009
Sugiyama1 tail cuff Heart rate and blood pressure. Conscious mice. inbred   (25) m 10wks 2007
Sundberg1 study archive Histopathology. Aging study. inbred   (28) both 2008
Sunde1 body weight
with selenium
Body weight curve 3 to 12 wks, control group. inbred w/CC8   (8) m 3-14wks 2018
Sunde1 RNA expression profiling
with selenium
Selenium regulation of selenoprotein enzyme activity and transcripts. inbred w/CC8   (8) m 3-14wks 2018
Svenson1 tail cuff Heart rate and blood pressure. Conscious mice. inbred   (14) both 9wks 2004
Taft1 assisted reproduction Performance following assisted reproductive technologies. inbred   (10) f various 2006
Tarantino1 body weight
with cocaine
Body weight inbred   (45) m 8-11wks 2015
Tarantino1 open field test
with cocaine
Locomotor activity. Baseline (saline) vs. cocaine 20 mg/kg i.p. 30 min test. inbred   (45) m 8-11wks 2015
Tarantino2 forced swim test
with ovariectomy
Mice with ovariectomy surgery vs. controls (sham surgery), 6 min test. inbred   (37) f 8-10wks 2016
Tarantino2 open field test
with ovariectomy
Locomotor activity and exploratory behavior. Mice with ovariectomy surgery vs. controls (sham surgery), 10 min test. inbred   (37) f 8-10wks 2016
Thomsen1 open field test
with cocaine
Locomotor activity. Baseline (saline) vs. cocaine i.p. (several doses). 1.3h and 2.3 h duration. inbred   (15) both 8-10wks 2011
Thomsen2 open field test
with R-6-Br-APB, quinelorane
Locomotor activity. Baseline (saline) vs. dopamine agonists i.p. (several doses). 3h session. inbred   (15) both 8-10wks 2011
Threadgill1 biomarker quantification
with acetaminophen
Liver cytochrome isoforms. Acetaminophen vs. control. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill1 histopathology
with acetaminophen
Liver histopathology, necrosis after acetaminophen vs. control. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill1 metabolic panel
with acetaminophen
Blood urea nitrogen, alanine transaminase, aspartate transaminase (serum), liver enzyme homeostasis. Acetaminophen (several doses) vs. control, several timepoints post-Rx. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill1 metabolite quantification
with acetaminophen
Liver protein homeostasis. Acetaminophen vs. control. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill1 organ weights
with acetaminophen
Liver weight after acetaminophen (several doses) vs. control. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Tomasini1 biomarker quantification Fibronectin. inbred   (25) both 9wks 2007
Tordoff1 body weight Body weight during testing. inbred   (28) m 9wks 2001
Tordoff1 bottle choice test Various salt solutions (several concentrations) vs. water. inbred   (28) m 9wks 2001
Tordoff2 body weight Body weight inbred   (28) m 4-12wks 2001
Tordoff2 intake monitoring Food intake, water intake. Daily. inbred   (28) m 4-12wks 2001
Tordoff3 body weight Body weight inbred w/CC7   (40) both 9-15wks 2002
Tordoff3 bottle choice test Various salt solutions (several concentrations) vs. water. inbred w/CC7   (40) both 9-15wks 2002
Tordoff3 DXA Body mass, fat mass, lean mass, bone mineral density and content. inbred w/CC7   (40) both 9-15wks 2002
Tordoff3 metabolic panel Ionized and total blood calcium, blood pH. inbred w/CC7   (40) both 9-15wks 2002
Tordoff3 monitoring system Bleeding time to collect approx 30 µL. inbred w/CC7   (40) both 9-15wks 2002
Trullas1 elevated plus maze Exploratory and anxiety-related behaviors. 5 min test. inbred   (16) m 6-8wks 1993
Trullas1 hormone quantification Corticosterone levels (plasma). Baseline vs. after stress (30 min in restraining cage). inbred   (16) m 6-8wks 1993
Trullas1 monitoring system Novelty-induced fear test. Eating inhibition due to novelty of environment. 10 min test. inbred   (16) m 6-8wks 1993
Trullas1 open field test Locomotor activity under dim lights vs. bright lights. 5 min test. inbred   (16) m 6-8wks 1993
UCLA1 genotyping SNP profiling, 132,000+ genomic locations, 1-19,X HMDP   (248) both 2018
UNC-GMUGA1 genotyping SNP profiling, 130,000+ genomic locations, 1-19,X,Y,MT. CC w/par   (77) m 2020
UNC-MMUGA2 genotyping SNP profiling, 76,000+ genomic locations, 1-19,X,MT CC w/par   (77) both 2017
Vinyard1 body weight Body weight inbred   (21) both 6-8wks 2009
Vinyard1 bone dimensions Craniofacial bone dimensions. inbred   (21) both 6-8wks 2009
Vulpe1 mineral quantification Liver mineral levels. Iron, copper, zinc. Iron homeostasis. inbred   (18) both 8wks 2010
Vulpe1 transferrin quantification Diferric transferrin (plasma). inbred   (18) both 8wks 2010
Wahlsten1 elevated plus maze Locomotor, exploratory, and anxiety-related behavior. inbred   (21) both 9, 12 wks 2003
Wahlsten1 histopathology Corpus callosum, hippocampus, anterior commisure. inbred   (21) both 9, 12 wks 2003
Wahlsten1 open field test Locomotor, exploratory, and anxiety-related behavior. 5 min test. inbred   (21) both 9, 12 wks 2003
Wahlsten1 organ weights Brain weight. inbred   (21) both 9, 12 wks 2003
Wahlsten2 behavior observation Wildness scoring during various phenotyping tests. inbred   (21) both 10-12wks 2003
Willott1 acoustic startle test Acoustic startle response, prepulse inhibition. inbred w/CC7   (40) both 5-6wks 2002
Willott1 body weight Body weight inbred w/CC7   (40) both 5-6wks 2002
Wiltshire1 elevated plus maze Locomotor activity. inbred   (38) both 12-14wks 2010
Wiltshire1 light-dark box Light-dark test. Anxiety-related behavior. inbred   (38) both 12-14wks 2010
Wiltshire1 open field test Locomotor activity. inbred   (38) both 12-14wks 2010
Wiltshire2 drug and metabolite quantification
with fluoxetine
Fluoxetine and norfluoxetine concentration (serum) after fluoxetine. inbred   (30) m 9-11wks 2011
Wiltshire2 open field test
with fluoxetine
Locomotor activity, exploratory and anxiety-related behavior. Fluoxetine-treated vs. control. 7 min test. inbred   (30) m 9-11wks 2011
Wiltshire2 tail suspension test
with fluoxetine
Immobility. Fluoxetine-treated vs. control. 5 min test. inbred   (30) m 9-11wks 2011
Wiltshire3 biomarker quantification
with fluoxetine
Brain tissue survey of 30 biochemical analytes. Fluoxetine-treated vs. control. 21d. inbred   (30) m 10-11wks 2011
Wiltshire4 immune cell quantification
with BEZ235, doxorubicin, idarubicin, selumetinib
In vitro study of 4 cancer chemotherapies (BEZ235, doxorubicin, idarubicin, selumetinib) vs. control. Effect on immune cells. Normalized data. inbred w/CC7   (36) m 10wks 2015
Xing1 ECG Heart rate and wave intervals. Conscious. Aging study, 6mo, 12mo, 20mo. inbred   (29) both 26, 52, 87 wks 2008
Xing2 gait analysis Aging study, 6mo, 12mo, 18mo. inbred   (31) both 26, 52, 78 wks 2010
Yuan1 body weight Aging study, 6mo, 12mo, and 18mo. inbred   (33) both 26, 52, 78 wks 2007
Yuan1 hormone quantification Insulin-like growth factor 1 (serum). Aging study, 6mo, 12mo, and 18mo. inbred   (33) both 26, 52, 78 wks 2007
Yuan2 colony observation Life span study. Survival curves. Aging study. inbred   (31) both max lifespan 2007
Yuan3 lipid profile Cholesterol (HDL). Aging study, 6mo, 12mo, 18mo. 4h fast, plasma. inbred   (32) both 26, 52, 78 wks 2008
Yuan3 metabolic panel Clinical blood chemistry. Aging study, 6mo, 12mo, 18mo. inbred   (32) both 26, 52, 78 wks 2008
Yuan4 colony observation Observed age at vaginal opening (patency). Aging study. inbred   (33) f 2-9wks 2009
Zimmermann1 body weight Body weight inbred   (30) both 7-15 wks 2020
Zimmermann1 intake monitoring Food and water intake; 2-day test, second day data analyzed during 12:12h light and dark periods. inbred   (30) both 7-15 wks 2020
Zimmermann1 monitoring system Voluntary activity and energy expenditure. 2-day test, second day data analyzed during 12:12h light and dark periods. inbred   (30) both 7-15 wks 2020